Home  >  Companies  >  Pathos
Pathos
AI-enabled clinical-stage biotech building a platform that uses multimodal oncology patient data and machine learning to identify patients, design and run more predictive clinical trials

Valuation

$3.00B

2026

Funding

$467.00M

2026

View PDF
Details
Headquarters
Chicago, United States
CEO
Iker Huerga
Website
Milestones
FOUNDING YEAR
2022

News

The latest coverage and announcements from Pathos.

View PDF
Details
Headquarters
Chicago, United States
CEO
Iker Huerga
Website
Milestones
FOUNDING YEAR
2022